Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?

Advances in Nutrition
Lena K BraheLesli H Larsen

Abstract

Obesity increases the risk of type 2 diabetes, cardiovascular diseases, and certain cancers, which are among the leading causes of death worldwide. Obesity and obesity-related metabolic diseases are characterized by specific alterations in the human gut microbiota. Experimental studies with gut microbiota transplantations in mice and in humans indicate that a specific gut microbiota composition can be the cause and not just the consequence of the obese state and metabolic disease, which suggests a potential for gut microbiota modulation in prevention and treatment of obesity-related metabolic diseases. In addition, dietary intervention studies have suggested that modulation of the gut microbiota can improve metabolic risk markers in humans, but a causal role of the gut microbiota in such studies has not yet been established. Here, we review and discuss the role of the gut microbiota in obesity-related metabolic diseases and the potential of dietary modulation of the gut microbiota in metabolic disease prevention and treatment.

References

Jun 1, 1991·The Journal of Applied Bacteriology·J H Cummings, G T Macfarlane
Jun 1, 1995·The Journal of Nutrition·G R Gibson, M B Roberfroid
Sep 1, 1996·Nucleic Acids Research·Y Van de PeerR De Wachter
Aug 7, 1997·The New England Journal of Medicine·M RosenbaumJ Hirsch
Feb 7, 2001·The American Journal of Clinical Nutrition·J H CummingsH N Englyst
May 13, 2003·The Proceedings of the Nutrition Society·Sandra Macfarlane, George T Macfarlane
Aug 11, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A DueA Astrup
Oct 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Apr 16, 2005·Science·Paul B EckburgDavid A Relman
Apr 21, 2005·European Journal of Clinical Nutrition·S J Lewis, S Burmeister
Jul 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ruth E LeyJeffrey I Gordon
Mar 7, 2006·Applied and Environmental Microbiology·Máire BegleyCormac G M Gahan
Apr 22, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Paul PoirierRobert H Eckel
Apr 25, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Giovanni FederspilRoberto Vettor
May 9, 2006·Molecular Microbiology·Erick Denamur, Ivan Matic
Jul 28, 2006·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Claude C RoyEmile Levy
Nov 9, 2006·American Journal of Physiology. Endocrinology and Metabolism·S J CreelyS Kumar
Nov 10, 2006·Critical Reviews in Food Science and Nutrition·Cheryl L Dikeman, George C Fahey
Dec 22, 2006·Nature·Ruth E LeyJeffrey I Gordon
Dec 22, 2006·Nature·Peter J TurnbaughJeffrey I Gordon
Jan 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Feb 22, 2007·The Journal of Nutrition·Michael Blaut, Thomas Clavel
Apr 26, 2007·Diabetes·Patrice D CaniRémy Burcelin
Oct 24, 2007·The Journal of Nutrition·Nathalie M DelzenneAudrey M Neyrinck
Mar 11, 2008·The American Journal of Clinical Nutrition·Marko KalliomäkiErika Isolauri
May 9, 2008·American Journal of Physiology. Renal Physiology·Daniel I LevySteve A N Goldstein
May 13, 2008·The American Journal of Clinical Nutrition·Jacques AmarJean Ferriéres
Aug 8, 2008·Journal of Clinical Gastroenterology·Maya PineiroKieran Tuohy
Sep 26, 2008·Journal of Lipid Research·Sarbani GhoshalErik Eckhardt
Dec 4, 2008·The Journal of Clinical Endocrinology and Metabolism·Giulio MarchesiniGabriele Forlani
Dec 2, 2008·Nature·Peter J TurnbaughJeffrey I Gordon
May 8, 2009·Diabetes & Metabolism·M SerinoR Burcelin
May 16, 2009·Current Pharmaceutical Design·Patrice D Cani, Nathalie M Delzenne
Jun 6, 2009·Obesity·Andreas SchwiertzPhilip D Hardt
Sep 29, 2009·Biochimica Et Biophysica Acta·Fredrik Bäckhed, Peter A Crawford
Oct 2, 2009·Current Diabetes Reports·Lalita KhaodhiarCaroline M Apovian
Jan 15, 2010·JAMA : the Journal of the American Medical Association·Katherine M FlegalLester R Curtin

❮ Previous
Next ❯

Citations

Jun 4, 2016·Current Oncology Reports·George Kunnackal John, Gerard E Mullin
Sep 15, 2016·Frontiers in Cellular and Infection Microbiology·Steve M HarakehEsam I Azhar
Aug 25, 2016·MBio·Marc A Sze, Patrick D Schloss
Sep 27, 2018·International Journal of Environmental Research and Public Health·Yoona Kim, Peter Clifton
Jan 14, 2018·Scientific Reports·Tariq Jamal KhanMuhammad Yasir
Feb 6, 2019·Advances in Nutrition·Amanda Cuevas-SierraJ Alfredo Martinez
Aug 23, 2017·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Line Quist BendtsenLesli Hingstrup Larsen
Jan 18, 2020·Annual Review of Food Science and Technology·Qixing NieMingyong Xie
Jul 21, 2017·Arquivos De Gastroenterologia·Maria do Carmo Friche Passos, Joaquim Prado Moraes-Filho
Aug 29, 2019·Frontiers in Endocrinology·Marina Di DomenicoMariarosaria Boccellino
Nov 30, 2019·Frontiers in Neuroscience·Luis Pedro MoreraMaría Daniela Defagó
Aug 28, 2020·Gut Microbes·Mirna ČokloSandra Kraljević Pavelić
Jan 9, 2019·Frontiers in Physiology·David PorrasSonia Sánchez-Campos
Jun 27, 2019·International Journal of Molecular Sciences·Fenglin ZhangSongbo Wang
Jan 8, 2020·Journal of Obesity & Metabolic Syndrome·Bohkyung KimJung-Eun Yim
Sep 22, 2018·The American Journal of Clinical Nutrition·Lars ChristensenMads F Hjorth
Mar 24, 2020·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Qingqing LvDifei Wang
Oct 8, 2020·International Journal of Environmental Research and Public Health·Oscar LorenzoJaime Ruiz-Tovar
Jan 19, 2021·Beneficial Microbes·X M Tomé-CastroP Roman
Dec 18, 2020·Rheumatology·Maxim B FreidinFrances M K Williams
Mar 17, 2021·Scientific Reports·Samuel F KingsleyHeidi A Tissenbaum
May 21, 2021·Advanced Materials·Giorgio ContaJun Chen
Aug 29, 2020·Journal of Agricultural and Food Chemistry·Ju HuQinwan Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.